Colorectal Cancer ranks as the third most commonly diagnosed cancer in Mauritius. Approximately 1 in 23 individuals in the general population will face a bowel cancer diagnosis at some point, affecting both men and women equally. Sadly, in Mauritius, only about 75% of patients diagnosed with bowel cancer survive beyond 2 years, underscoring the urgency of early detection to prevent fatalities from this disease.
Most colorectal cancers stem from precancerous growths known as polyps. Early detection allows for the complete removal of polyps, significantly reducing the risk of cancer development. The primary goal of bowel cancer screening is to detect polyps and cancers at an early, treatable stage.
Following the Colorectal Cancer Conference and the establishment of the National Committee on Bowel Cancer Screening, we are now on the cusp of implementing the screening program. Initially targeting individuals turning 60, we plan to expand the program gradually over the coming years. Participants will provide stool samples for analysis of human faecal haemoglobin (FIT). We've collaborated closely with the laboratory to ensure all FIT tests are conducted in-house, with results promptly available.
A positive FIT result prompts further evaluation with a colonoscopy, scheduled within a maximum of 2 weeks. About 2.5% of participants are expected to have a positive FIT. Those with negative results will be invited to participate again in 2-3 years.
We're thrilled to launch this program as we anticipate a significant positive impact on our population and a decrease in colorectal cancer cases we are currently seeing.